MARKET

AKTS

AKTS

AKTIS ONCOLOGY INC
NASDAQ
17.80
-1.20
-6.32%
Closed 19:45 02/10 EST
OPEN
18.90
PREV CLOSE
19.00
HIGH
19.30
LOW
17.65
VOLUME
430.37K
TURNOVER
--
52 WEEK HIGH
29.16
52 WEEK LOW
17.65
MARKET CAP
934.90M
P/E (TTM)
-9.7390
1D
5D
1M
3M
1Y
5Y
1D
Assessing Aktis Oncology (AKTS) Valuation After Recent Share Price Weakness And Negative Price To Book Ratio
Simply Wall St · 1d ago
Weekly Report: what happened at AKTS last week (0202-0206)?
Weekly Report · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Allurion, Rithm Capital, Medtronic
Reuters · 02/03 18:47
BUZZ-J.P. Morgan initiates coverage of Aktis Oncology with 'overweight' rating
Reuters · 02/03 16:01
AKTIS ONCOLOGY INC <AKTS.O>: BOFA GLOBAL RESEARCH INITIATES COVERAGE WITH BUY RATING; PRICE OBJECTIVE $34
Reuters · 02/03 14:56
Adobe downgraded, Palantir upgraded: Wall Street’s top analyst calls
TipRanks · 02/03 14:35
This GCI Liberty Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
Benzinga · 02/03 14:10
Aktis Oncology Price Target Announced at $31.00/Share by Leerink Partners
Dow Jones · 02/03 12:39
More
About AKTS
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.

Webull offers Aktis Oncology, Inc. stock information, including NASDAQ: AKTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKTS stock methods without spending real money on the virtual paper trading platform.